Endocannabinoid System Research: Cannabis in Prenatal Care
Prenatal cannabis polysubstance use is a significant concern in maternal health research. This study highlights the patterns and risks of cannabis combined with other substances during pregnancy. Understanding these patterns aids clinicians in providing…
Clinical Research on Full-Spectrum Cannabis Extract VER-01 for Back Pain
The full-spectrum cannabis extract VER-01 was evaluated in a phase 3 clinical trial for chronic low back pain. This study demonstrated meaningful pain reduction and safety over 12 weeks and extended follow-up. VER-01 offers promising evidence as a…
Self-reported reasons for medical and nonmedical cannabis use in Australia: A cross-sectional analysis of the International Cannabis Policy Study 2023.
This study highlights dual-use cannabis consumption among Australian adults, showing that many combine medical and nonmedical cannabis. Dual-use cannabis consumption represents a significant portion of users, reflecting real-world use beyond regulatory…
Impact of Preoperative Marijuana Use on Functional Recovery and Complications After Spinopelvic Fusion in Adult Spinal Deformity.
With the rising prevalence of marijuana use and increasing rates of complex spinal deformity surgeries, understanding the impact of preoperative marijuana use is critical. This study examines how preoperative marijuana use influences functional recovery…
Cannabidiol for Fibromyalgia: Clinical Trial Evidence and Analysis
This cannabidiol clinical trial fibromyalgia study found no superiority of CBD over placebo in reducing pain. The trial highlights the gap between patient use and clinical evidence. Clinicians should guide fibromyalgia patients based on evolving research.
Endocannabinoid System Research: Cannabis for Anxiety Care
Endocannabinoid system cannabis anxiety care research highlights the clinical importance of cannabinoid composition and product type. Cannabis use for anxiety relief varies significantly between flower and edible products. Understanding these differences…
Cannabinoids for Autism: Clinical Research Systematic Review
Therapeutic use cannabis derivatives autism has been studied in clinical trials showing reductions in behavioral symptoms in children with autism. Cannabidiol-rich preparations demonstrated improvements in social responsiveness and quality of life.…
Endocannabinoid Research: Cannabis Use in Pregnancy & ASD
Maternal cannabis use pregnancy risks include a small but measurable increase in autism spectrum disorder and ADHD in offspring. Cannabis compounds cross the placenta and may affect fetal brain development. Current evidence advises avoiding cannabis use…
Topical Cannabis for AIMSS: Medical Cannabis Evidence-Based Care
Topical cannabinoids for AIMSS offer a promising approach to managing joint pain and stiffness caused by aromatase inhibitor therapy. Clinical trials show these balms are generally well-tolerated and feasible for use. This evidence-based care option may…
Impact of Daily Broad-Spectrum CBD Use on WADA Prohibited Cannabinoids
Daily broad-spectrum CBD use at 150 mg per day produces detectable urinary concentrations of WADA prohibited cannabinoids. Exercise further amplifies these cannabinoid levels in athletes. This study highlights doping risks associated with broad-spectrum…